Immediate Implant Placement Using Socket Shield With CGF

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCairo University

About this trial

This prospective case series study aims to clinically and radiographically evaluate the effectiveness of the socket shield technique combined with concentrated growth factors (CGF) in immediate implant placement in the esthetic zone. Outcomes will include crestal bone level changes assessed by CBCT and implant stability measured using Osstell.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥18 years old. (Younis, W., & El-Rashidy, A. 2020).

Both male and female patients.

Maxillary, anterior and premolar segment.

Disqualifiers

A medical history that contraindicates oral surgical treatment such as (uncontrolled/untreated diabetes mellitus, immuno-compromised status, radio or chemotherapy of the oral and maxillofacial region, treatment with oral and/or intravenous bisphosphonates).

Presence of active or untreated periodontal disease.

Vertical root fractures involving the buccal aspect.

Tooth /teeth with horizontal fractures below bone level.

Trial design

Design model

Single group

Treatments tested in this trial

  • Immediate implant placement with Socket Shield Technique and CGF

    Procedure/Surgery

    Partial extraction therapy using the socket shield technique followed by immediate implant placement. Concentrated growth factors prepared from autologous blood will be packed in the jumping gap to enhance bone regeneration and healing.

Treatment groups

7 Participants
are divided into 1 treatment group
Group A: Socket Shield Technique with CGFExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Crestal bone level

Radiographic evaluation of crestal bone level changes around the implant using CBCT, measured in millimeters (mm).

Time frame
2 weeks and 6 months post-operatively

Secondary outcomes

1

Implant stability

Implant stability will be assessed using resonance frequency analysis with the Osstell device and recorded as Implant Stability Quotient (ISQ). ISQ values range from 1 to 100, where higher values indicate greater implant stability and a better outcome.

Time frame
Immediately after implant placement and at 6 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: